Successful long-term effects of direct renin inhibitor aliskiren in a patient with atherosclerotic renovascular hypertension

CEN Case Reports
Norihiko MorisawaTakashi Yokoo

Abstract

A 64-year-old man visited our hospital with complaints of misty vision and ophthalmalgia. On admission, his blood pressure (BP) was high at 220/135 mmHg with no past history of hypertension, and he had choked discs. He was tentatively diagnosed as having idiopathic intracranial hypertension, and was later found to have atherosclerotic unilateral renovascular hypertension (RVH) based upon the extremely high plasma renin activity together with the radiological image tests. On day 3, combined antihypertensive therapies consisting of oral angiotensin II receptor blocker (ARB) and Ca channel blocker (CCB) along with intravenous CCB induced an abrupt BP lowering which led to deterioration of his renal function, progressing into acute kidney injury (AKI). Cessation of the ARB and reduction of the CCB dose ameliorated the AKI-related decline in renal function. On day 17, as he was reluctant to receive surgical intervention, he was treated with a direct renin inhibitor, aliskiren, combined with a half-dose CCB as a maintenance antihypertensive therapy. The therapy has proven not only successful to chronically maintain his renal function but was also capable of controlling his BP in the neighborhood of 130/85 mmHg over a period of 2 year...Continue Reading

References

Jul 23, 1994·Lancet·F H Derkx, M A Schalekamp
Nov 13, 1998·American Heart Journal·J J CrowleyP J Conlon
Feb 15, 2001·The New England Journal of Medicine·R D Safian, S C Textor
Aug 19, 2007·Journal of Cardiovascular Pharmacology·A H Jan Danser
Jun 19, 2008·Circulation·Naomi D L FisherNorman K Hollenberg
May 1, 2008·Circulation. Heart Failure·John J V McMurrayUNKNOWN Aliskiren Observation of Heart Failure Treatment (ALOFT) Investigators
Nov 13, 2009·The New England Journal of Medicine·UNKNOWN ASTRAL InvestigatorsJohn Scoble
Nov 13, 2009·The New England Journal of Medicine·Lance D Dworkin, Christopher J Cooper
Mar 21, 2012·European Journal of Heart Failure·John J V McMurrayHenry Krum
Mar 27, 2013·Clinical and Experimental Nephrology·Masayuki Tanemoto
Aug 2, 2013·Circulation Journal : Official Journal of the Japanese Circulation Society·Katsuyuki MiuraTakayoshi Ohkubo
Nov 20, 2013·The New England Journal of Medicine·Christopher J CooperUNKNOWN CORAL Investigators
Feb 28, 2016·Life Sciences·Sandeep Kaur, Arunachalam Muthuraman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.